Denosumab Decreases Cortical Porosity in Postmenopausal Women with Low BMD
Steven K. Boyd(Alberta Bone and Joint Health Institute), Ego Seeman(The University of Melbourne), Stéphanie Boutroy(Université Claude Bernard Lyon 1), David A. Hanley(The University of Sydney), Kyle K. Nishiyama(University of Calgary), Matthew S. Austin(Hospital for Special Surgery), Thierry Thomas(Lyon 1 Université), Roger Zebaze, Cesar Libanati(Amgen (United States)), César E. Bogado(Universidad del Salvador), José Zanchetta(Universidad del Salvador)
Cited by 0
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k